Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 10:16 PM
Study NCT ID:
NCT00351858
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2006-07-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer
Sponsor:
Neovii Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-07-12
First Submit QC Date:
None
Study First Post Date:
2006-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-30
Last Update Post Date:
2015-05-01
Last Update Post Date Type:
ESTIMATED